Movement Disorders Rating Scale for Children Aged 0-3 years: A Revision Study Design

IF 2.1 3区医学 Q2 CLINICAL NEUROLOGY

Pediatric neurology Pub Date : 2025-08-05 DOI:10.1016/j.pediatrneurol.2025.07.012

Roberta Battini MD, PhD , Roberta Scalise MD, PhD , Valentina Menici PT, PhD , Eleonora Gazzanelli PT , Eleonora Bonaventura MD , Roberta Di Pietro PT , Camilla Antonelli MD, PhD , Andrea Guzzetta MD, PhD , Giuseppina Sgandurra MD, PhD , Giovanni Cioni MD

{"title":"Movement Disorders Rating Scale for Children Aged 0-3 years: A Revision Study Design","authors":"Roberta Battini MD, PhD , Roberta Scalise MD, PhD , Valentina Menici PT, PhD , Eleonora Gazzanelli PT , Eleonora Bonaventura MD , Roberta Di Pietro PT , Camilla Antonelli MD, PhD , Andrea Guzzetta MD, PhD , Giuseppina Sgandurra MD, PhD , Giovanni Cioni MD","doi":"10.1016/j.pediatrneurol.2025.07.012","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Movement Disorders - Childhood Rating Scale (MD-CRS 0-3) is a tool aimed to evaluate movement disorders in the first 3 years of life; however, with the experience gained in 10 years clinical practice, it has been possible, and necessary, to improve the characterization of the scale defining age-appropriate tasks according to age time windows and moving the MD severity from a three-point to a five-point scoring system. By using the scale in our clinical practice and in research, we realized that it was necessary to have more quantitative specifications, allowing a more precise scoring and a better definition of the psychometric properties. This study is a measurement-focused study of recorded video sessions and of video sessions which were carried out in in- and out-patient settings of IRCCS Fondazione Stella Maris aiming to revise the MD-CRS 0-3 and created the MD-CRS 0-3 R to promote and increase its use by improving its structure and items.</div></div><div><h3>Methods</h3><div>A clinical sample of 90 eligible individuals—30 females and 60 males, mean age 2 years and 6 months, and age range 3 months – 3 years and 11 months—was included. Five raters independently and blindly scored the videotapes according to the MD-CRS 0-3 and the MD-CRS 0-3 R, with an interval of at least 6 months.</div></div><div><h3>Results</h3><div>Inter-rater and Intraclass Correlation Coefficient values in all indexes of MD-CRS 0-3 R all exceeded 0.85. Standard Errors of the Measurement and Minimally Detectable Differences were very low. Overall, the MD-CRS 0-3 R exhibited improved psychometric properties compared to the original scale.</div></div><div><h3>Conclusions</h3><div>The present study supports the use of the revised MD-CRS 0-3 in children under 4 years as a trustworthy, sensitive tool as for longitudinal assessments of movement disorder severity.</div></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"171 ","pages":"Pages 100-106"},"PeriodicalIF":2.1000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric neurology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0887899425002140","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Movement Disorders - Childhood Rating Scale (MD-CRS 0-3) is a tool aimed to evaluate movement disorders in the first 3 years of life; however, with the experience gained in 10 years clinical practice, it has been possible, and necessary, to improve the characterization of the scale defining age-appropriate tasks according to age time windows and moving the MD severity from a three-point to a five-point scoring system. By using the scale in our clinical practice and in research, we realized that it was necessary to have more quantitative specifications, allowing a more precise scoring and a better definition of the psychometric properties. This study is a measurement-focused study of recorded video sessions and of video sessions which were carried out in in- and out-patient settings of IRCCS Fondazione Stella Maris aiming to revise the MD-CRS 0-3 and created the MD-CRS 0-3 R to promote and increase its use by improving its structure and items.

Methods

A clinical sample of 90 eligible individuals—30 females and 60 males, mean age 2 years and 6 months, and age range 3 months – 3 years and 11 months—was included. Five raters independently and blindly scored the videotapes according to the MD-CRS 0-3 and the MD-CRS 0-3 R, with an interval of at least 6 months.

Results

Inter-rater and Intraclass Correlation Coefficient values in all indexes of MD-CRS 0-3 R all exceeded 0.85. Standard Errors of the Measurement and Minimally Detectable Differences were very low. Overall, the MD-CRS 0-3 R exhibited improved psychometric properties compared to the original scale.

Conclusions

The present study supports the use of the revised MD-CRS 0-3 in children under 4 years as a trustworthy, sensitive tool as for longitudinal assessments of movement disorder severity.

查看原文本刊更多论文

0-3岁儿童运动障碍评定量表：修订研究设计

运动障碍-儿童评定量表（MD-CRS 0-3）是一种旨在评估生命前3年运动障碍的工具；然而，根据10年的临床实践经验，有可能而且有必要根据年龄时间窗来改进量表的特征，定义适合年龄的任务，并将MD严重程度从3分评分系统改为5分评分系统。通过在我们的临床实践和研究中使用量表，我们意识到有必要有更多的定量规范，允许更精确的评分和更好的定义心理测量属性。本研究以测量为重点，对IRCCS基金会Stella Maris在门诊和门诊进行的录像会话和录像会话进行了研究，旨在修订MD-CRS 0-3，并创建MD-CRS 0-3 R，通过改进其结构和项目来促进和增加其使用。方法选取符合条件的患者90例，其中女性30例，男性60例，平均年龄2岁6个月，年龄范围3个月~ 3岁11个月。5名评分员根据MD-CRS 0-3和MD-CRS 0-3 R进行独立盲目评分，评分间隔至少为6个月。结果MD-CRS 0 ~ 3r各指标间、类内相关系数均大于0.85。测量的标准误差和最小可检测的差异非常低。总体而言，MD-CRS 0- 3r与原始量表相比表现出改善的心理测量特性。结论本研究支持在4岁以下儿童中使用修订后的MD-CRS 0-3作为一种可靠、敏感的纵向评估运动障碍严重程度的工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric neurology 医学-临床神经学

CiteScore

4.80

自引率

2.60%

发文量

176

审稿时长

78 days

期刊介绍： Pediatric Neurology publishes timely peer-reviewed clinical and research articles covering all aspects of the developing nervous system. Pediatric Neurology features up-to-the-minute publication of the latest advances in the diagnosis, management, and treatment of pediatric neurologic disorders. The journal''s editor, E. Steve Roach, in conjunction with the team of Associate Editors, heads an internationally recognized editorial board, ensuring the most authoritative and extensive coverage of the field. Among the topics covered are: epilepsy, mitochondrial diseases, congenital malformations, chromosomopathies, peripheral neuropathies, perinatal and childhood stroke, cerebral palsy, as well as other diseases affecting the developing nervous system.